New diabetes clinical trial: Carvedilol + Simvastatin vs. Carvedilol Alone for Chronic Liver Disease and Cirrhotic Cardiomyopathy and Its Impact on Hepatic Decompensation and Survival; a Double-blind Randomized Controlled Trial

Published on: May 28, 2024 at 11:00PM
Conditions: Decompensated Cirrhosis; Cirrhotic Cardiomyopathy; Cirrhosis, Liver; Left Ventricular Diastolic Dysfunction; Acute Kidney Injury
Interventions: Drug: Simvastatin 20mg; Drug: Carvedilol 3.125 mg
Sponsors: Post Graduate Institute of Medical Education and Research, Chandigarh; Indian Council of Medical Research
Not yet recruiting